Stock TYRA TYRA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Tyra Biosciences, Inc.

Equities

TYRA

US90240B1061

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
19.78 USD -0.10% Intraday chart for Tyra Biosciences, Inc. +21.95% +42.82%
May. 13 Oppenheimer Adjusts Tyra Biosciences Price Target to $28 From $25, Maintains Outperform Rating MT
May. 09 Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tyra Biosciences to Present at Upcoming Investor Conferences
PR
Oppenheimer Adjusts Tyra Biosciences Price Target to $28 From $25, Maintains Outperform Rating
MT
Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
PR
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
PR
Tyra Biosciences, Inc. Announces Board Changes
CI
HC Wainwright Adjusts Tyra Biosciences Price Target to $23 From $19, Maintains Buy Rating
MT
Tyra Biosciences Q4 Net Loss Widens
MT
Tyra Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
PR
Tyra Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Transcript : Tyra Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:00 AM
Tyra Biosciences to Present at Upcoming Investor Conferences
PR
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
PR
Tyra Biosciences, Inc. announced that it has received $200.006021 million in funding from RA Capital Management, L.P., Boxer Capital LLC, BVF Partners L.P., Nextech Invest Ltd., OrbiMed Advisors LLC, 5AM Venture Management, LLC
CI
Wedbush Lifts Tyra Biosciences' PT to $28 From $27, Tweaks Financing Assumptions; Keeps Outperform Rating
MT
Sector Update: Health Care Stocks Advance Late Afternoon
MT
Sector Update: Health Care
MT
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise
MT
Top Midday Gainers
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TYRA Stock
  4. News Tyra Biosciences, Inc.